Minerva Neurosciences Stock Explodes 276% on Massive $200 Million Funding Boost for Game-Changing Schizophrenia Treatment
Folks, if you’re glued to the markets like I am, you’ve probably seen the fireworks today. Minerva Neurosciences (NERV), a biotech player laser-focused on brain health breakthroughs, just lit up the board with one of the wildest single-day surges we’ve had in ages. As of this writing, shares are rocketing up over 275% to around … Read more